Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28036586 | 0.76 | ALDH1A1 (0.36) | ALDH1A1KMT2AKDM4EMEN1HPGD | |
| Ammonia Solution, Strong SCHEMBL29243780 | 0.74 | ALDH1A1 (0.35) | ALDH1A1KMT2AKDM4EMEN1HPGD | |
| SCHEMBL2514772 | 0.68 | CYP2E1 (0.33) | ALDH1A1KMT2AKDM4EMEN1HPGD | |
| SCHEMBL17616423 | 0.67 | ALDH1A1 (0.33) | ALDH1A1KMT2APOLB | |
| Perchlorate SCHEMBL30215899 | 0.67 | ALDH1A1 (0.35) | ALDH1A1KMT2AKDM4EPOLB | |
| SCHEMBL19622429 | 0.66 | KMT2A (0.35) | ALDH1A1KMT2APOLB | |
| SCHEMBL422557 | 0.66 | ACHE (0.33) | — | |
| SCHEMBL23867480 | 0.65 | FDPS (0.38) | ALDH1A1KMT2APOLB | |
| SCHEMBL22672901 | 0.63 | ALDH1A1 (0.34) | ALDH1A1KMT2APOLB | |
| SCHEMBL14459642 | 0.63 | ALDH1A1 (0.41) | ALDH1A1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8637601-B2 | Fluorine-containing polymer having heteroaromatic ring | DAIKIN INDUSTRIES, LTD. (JP) | 2014-01-28 | — | — | US | disclosed |
| EP-1983008-B1 | FLUORINE-CONTAINING POLYMER CONTAINING HETEROAROMATIC RING | DAIKIN IND LTD (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-20120271005-A1 | FLUORINE-CONTAINING POLYMER HAVING HETEROAROMATIC RING | DAIKIN INDUSTRIES, LTD. (JP) | 2012-10-25 | — | — | US | disclosed |
| US-8252944-B2 | Process for preparing heteroaromatic ring compound having N-Rf group | DAIKIN INDUSTRIES, LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-8236887-B2 | Fluorine-containing polymer having heteroaromatic ring | DAIKIN INDUSTRIES, LTD. (JP) | 2012-08-07 | — | — | US | disclosed |
| US-8212053-B2 | Process for preparing heteroaromatic ring compound having N-Rf group | DAIKIN INDUSTRIES, LTD. (JP) | 2012-07-03 | — | — | US | disclosed |
| US-20120116097-A1 | PROCESS FOR PREPARING HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP | DAIKIN INDUSTRIES, LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20100222598-A1 | PROCESS FOR PREPARING HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP | DAIKIN INDUSTRIES, LTD. (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20090105400-A1 | Imidazolium side chains for example; for example polymers based on 1-methyl-3-(2H,9H,9H-perfluoro-3,6-dioxa-5-methyl-8-nonenyl)-imidazolium trifluoromethanesulfonate; polymer electrolytes for fuel cell, secondary battery, capacitor, dye-sensitized solar cell and electrochromic device | DAIKIN INDUSTRIES, LTD. (JP) | 2009-04-23 | — | — | US | disclosed |
| EP-1983008-A1 | FLUORINE-CONTAINING POLYMER CONTAINING HETEROAROMATIC RING | Daikin Industries, Ltd. (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1975157-A1 | METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP | Daikin Industries, Ltd. (JP) | 2008-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222598-A1 | PROCESS FOR PREPARING HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP | CYP2F1, AFF1, AFF2 | ALDH1A1 2332/4885KMT2A 980/4885KDM4E 1826/4885 |
| US-20120116097-A1 | PROCESS FOR PREPARING HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP | CYP2F1, AFF1, AFF2 | ALDH1A1 2332/4885KMT2A 980/4885KDM4E 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.